Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosup Rew

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Medicinal Chemistry|June 17, 2008
Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo modelLisa D Julian, Zhulun Wang, Tracy Bostick, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or BioisostereGwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Journal of Medicinal Chemistry|April 25, 2012
Structure-based design of novel inhibitors of the MDM2-p53 interactionYosup Rew, Daqing Sun, Felix Gonzalez-Lopez De Turiso, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of AM-7209, a potent and selective 4-amidobenzoic acid inhibitor of the MDM2-p53 interactionYosup Rew, Daqing Sun, Xuelei Yan, et al.
Journal of Medicinal Chemistry|February 20, 2014
Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interactionAna Z Gonzalez, John Eksterowicz, Michael D Bartberger, et al.
Journal of Medicinal Chemistry|January 25, 2014
Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical developmentDaqing Sun, Zhihong Li, Yosup Rew, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Medicinal Chemistry|June 17, 2008
Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo modelLisa D Julian, Zhulun Wang, Tracy Bostick, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or BioisostereGwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Journal of Medicinal Chemistry|April 25, 2012
Structure-based design of novel inhibitors of the MDM2-p53 interactionYosup Rew, Daqing Sun, Felix Gonzalez-Lopez De Turiso, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of AM-7209, a potent and selective 4-amidobenzoic acid inhibitor of the MDM2-p53 interactionYosup Rew, Daqing Sun, Xuelei Yan, et al.
Journal of Medicinal Chemistry|February 20, 2014
Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interactionAna Z Gonzalez, John Eksterowicz, Michael D Bartberger, et al.
Journal of Medicinal Chemistry|January 25, 2014
Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical developmentDaqing Sun, Zhihong Li, Yosup Rew, et al.
Pageof 3